Journal profile · Urology & Nephrology
Therapeutic Apheresis and Dialysis
ISSN 1744-9979 · eISSN 1744-9987 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Bimonthly · Founded 2003
Therapeutic Apheresis and Dialysis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.49; hybrid open access; APC about USD 3,350; median 91 days to acceptance (83 articles, last 24 months); community-reported acceptance: fairly easy; 150 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Therapeutic Apheresis and Dialysis is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dialysis and Renal Disease Management, Complement system in diseases and Parathyroid Disorders and Treatments, together about 37.1% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Therapeutic Apheresis and Dialysis is the official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy. The Journal publishes original articles, review articles, letters, editorials and guidelines on apheresis and dialysis technologies and treatments.
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Editor-in-chief Germany Bernd HohensteinPublisher website
Editorial board by country: none in mainland China; most named Japan 3, Austria 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dialysis and Renal Disease ManagementMedicine21.4%
- Complement system in diseasesImmunology and Microbiology8.2%
- Parathyroid Disorders and TreatmentsMedicine7.6%
- Central Venous Catheters and HemodialysisHealth Professions6.8%
- Acute Kidney Injury ResearchMedicine5%
- Pharmacological Effects and Toxicity StudiesMedicine3.8%
- Chronic Kidney Disease and DiabetesMedicine3.5%
- Renal Diseases and GlomerulopathiesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.49LetPub ·
- Impact factor (publisher)
- 1.5Publisher website ·
- Impact factor (publisher) 2025
- 1.5Publisher website ·
- CiteScore 2026-06
- 3LetPub ·
- CiteScore (publisher)
- 3Publisher website ·
- CiteScore (publisher) 2025
- 3Publisher website ·
- SJR 2026-06
- 0.45LetPub ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 49LetPub ·
- h-index
- 71OpenAlex ·
- i10-index
- 1,248OpenAlex ·
- 2-year mean citedness
- 1.12OpenAlex ·
- Self-citation rate
- 6.7%LetPub ·
- Share of gold OA articles
- 16.01%LetPub ·
Volume
- Articles per year
- 88LetPub ·
- Articles per year (publisher) 2025
- 126Publisher website ·
- Downloads per year (publisher) 2025
- 161,304Publisher website ·
Articles by year OpenAlex count · 3,801 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 119 | 44 | 15 |
| 2025 | 150 | 72 | 118 |
| 2024 | 146 | 67 | 330 |
| 2023 | 140 | 64 | 355 |
| 2022 | 188 | 45 | 829 |
| 2021 | 173 | 50 | 1,128 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
91 daysMedian, submission to acceptance · P25–P75 57 days – 135 days
- Acceptance to online
- median 10 days (83 articles)
- Submission to online
- median 104 days
- Sample
- 83 articles with submission and acceptance dates (291 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 25%Publisher website ·
- Acceptance rate (publisher) 2025
- 25%Publisher website ·
- Submission to first decision
- 13 daysPublisher website ·
- Submission to first decision 2025
- 13 daysPublisher website ·
- Submission to acceptance 2025
- 79 daysPublisher website ·
- Acceptance to publication 2025
- 9 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,350 / EUR 2,780 / GBP 2,220 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 150 words
- Keywords
- ≤ 5
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted7
- case reportArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- editorialArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- letterArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- letter to the editorArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- original articleArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- reviewArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
- review articleArticle Type Description Main Text Word Limit Abstract / Structure / Word Limit Other Requirements Original Article Reports of new research findings or conceptu…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- AI use Disclosing the Use of Artificial Intelligence (AI)
If you or your co-authors have used Artificial Intelligence Generated Content (AIGC) tools such as ChatGPT and others based on large language models (LLMs) to develop any portion of a manuscript, their use must be described transparently and in detail in the Methods section.Find more details on Wiley’s AI guidelines for researchers and Wiley’s AI policy in full in the Best Practices Guidelines on …
Source ↗Publisher website ·- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria.
Source ↗Publisher website ·- Conflicts of interest Disclosure
Authors should declare any interest, financial support or relationship that may pose conflict of interest in the Covering Letter and Disclosure in all manuscript types.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics
COPE core practices Model summary
This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access Open Access
This journal is a subscription journal that offers an open access option. You’ll have the option to choose to make your article open access after acceptance, which will be subject to an APC. For more information on this journal’s APCs, please see the Open Access page.
Source ↗Publisher website ·- Peer review 1. Submission and Peer Review Process
Once the submission materials have been prepared in accordance with the author guidelines, new submissions should be made via the Wiley Authors submission portal: https://authors.wiley.com/journal/TAP.
Source ↗Publisher website ·- Plagiarism
iThenticate CrossCheck for plagiarism detection Model summary
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints Preprint policy
Preprint policy Model summary
Please find the Wiley preprint policy here.This journal accepts articles previously published on preprint servers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2003
- ISSN
- 1744-9979
- Electronic ISSN
- 1744-9987
- Society / sponsor
- International Society for Apheresis and the Japanese Society for Apheresis
- Latest issue on the website
- Volume 30, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Therapeutic Apheresis and Dialysis
What CAS zone is Therapeutic Apheresis and Dialysis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Therapeutic Apheresis and Dialysis is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Therapeutic Apheresis and Dialysis?
The latest impact factor listed by LetPub is 1.49; CiteScore 3, h-index 71.
How long does peer review take at Therapeutic Apheresis and Dialysis?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 57–135 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 25% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Therapeutic Apheresis and Dialysis?
According to the journal's author guidelines: Abstract: ≤ 150 words; Keywords: ≤ 5; Manuscript length: ≤ 5,000 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Therapeutic Apheresis and Dialysis based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Japan (3) and Austria (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Therapeutic Apheresis and Dialysis?
According to LetPub and DOAJ records, Therapeutic Apheresis and Dialysis is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Therapeutic Apheresis and Dialysis open access, and what is the APC?
Therapeutic Apheresis and Dialysis is a hybrid journal. For open-access publication: APC about USD 3,350.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .